Harmony Biosciences Announces Winners of Patients at the Heart and Progress at the Heart on Third Annual World Narcolepsy Day

PLYMOUTH MEETING, Pa., Sept. 22, 2021 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced winners of the…

About the Author

has written 20655 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com